Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin-assisted-psychotherapy in Adults With Cannabis Use Disorder
NCT06225232Phase 2Active, not recruiting
- Sponsor
- McMaster University
- Start
- Mar 2025
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of psilocybin in cannabis use disorder (CUD), sponsored by McMaster University. Started Mar 2025; status: active, not recruiting.
02
Drugs
psilocybin
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT06225232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06225232.